Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
ResQ Pharma, Inc.
See All Filings
|
D | 2020-09-10 12:27:12 |
Amount To Be Raised
$2,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001668333
Filed Document
0001668333-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-09-10 12:27:12
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ResQ Pharma, Inc.
See All Filings
|
D | 2024-12-31 08:48:54 |
Amount To Be Raised
$100,000
Associated Brokers / Dealers
N/A
CIK Number
0001668333
Filed Document
0001668333-24-000002
Exclusions or Exemptions
506b
Accepted Date
2024-12-31 08:48:54
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ResQ Pharma, Inc.
See All Filings
|
D | 2016-09-15 18:34:05 |
Amount To Be Raised
$764,500
Associated Brokers / Dealers
N/A
CIK Number
0001668333
Filed Document
0001668333-16-000002
Exclusions or Exemptions
506b
Accepted Date
2016-09-15 18:34:05
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ResQ Pharma, Inc.
See All Filings
|
D | 2016-03-02 |
Amount To Be Raised
$325,000
Associated Brokers / Dealers
N/A
CIK Number
0001668333
Filed Document
0001668333-16-000001
Exclusions or Exemptions
506b
Accepted Date
2016-03-02
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
ResQ Pharma, Inc.
See All Filings
|
D | 2022-06-16 16:58:06 |
Amount To Be Raised
$300,000
Associated Brokers / Dealers
N/A
CIK Number
0001668333
Filed Document
0001668333-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-06-16 16:58:06
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
ILLINOIS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|